BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrosillo N, Taglietti F, Granata G. Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future. J Clin Med 2019;8:E934. [PMID: 31261755 DOI: 10.3390/jcm8070934] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Rossolini GM, Stone GG. Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015–2017). International Journal of Antimicrobial Agents 2020;56:106111. [DOI: 10.1016/j.ijantimicag.2020.106111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Florio W, Rizzato C, Becherini S, Guazzelli L, D'Andrea F, Lupetti A. Synergistic activity between colistin and the ionic liquids 1-methyl-3-dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1-dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria. J Glob Antimicrob Resist 2020;21:99-104. [PMID: 32298808 DOI: 10.1016/j.jgar.2020.03.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Majumder MAA, Singh K, Hilaire MG, Rahman S, Sa B, Haque M. Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula. Expert Rev Anti Infect Ther 2020;18:1245-58. [PMID: 32684048 DOI: 10.1080/14787210.2020.1796638] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gogry FA, Siddiqui MT, Sultan I, Haq QMR. Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria. Front Med (Lausanne) 2021;8:677720. [PMID: 34476235 DOI: 10.3389/fmed.2021.677720] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ayoub Moubareck C. Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance. Membranes (Basel) 2020;10:E181. [PMID: 32784516 DOI: 10.3390/membranes10080181] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
6 Stefaniuk EM, Kozińska A, Waśko I, Baraniak A, Tyski S. Occurrence of Beta-Lactamases in Colistin-Resistant Enterobacterales Strains in Poland - a Pilot Study. Pol J Microbiol 2021;70:283-8. [PMID: 34349817 DOI: 10.33073/pjm-2021-021] [Reference Citation Analysis]
7 Walker KA, Treat LP, Sepúlveda VE, Miller VL. The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae. mBio 2020;11:e01750-20. [PMID: 32963003 DOI: 10.1128/mBio.01750-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
8 Gupta M, Naik AK, Singh SK. Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon 2019;5:e02956. [PMID: 31886427 DOI: 10.1016/j.heliyon.2019.e02956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Singh S, Pathak A, Rahman M, Singh A, Nag S, Sahu C, Prasad KN. Genetic Characterisation of Colistin Resistant Klebsiella pneumoniae Clinical Isolates From North India. Front Cell Infect Microbiol 2021;11:666030. [PMID: 34235092 DOI: 10.3389/fcimb.2021.666030] [Reference Citation Analysis]
10 Shein AMS, Wannigama DL, Higgins PG, Hurst C, Abe S, Hongsing P, Chantaravisoot N, Saethang T, Luk-In S, Liao T, Nilgate S, Rirerm U, Kueakulpattana N, Laowansiri M, Srisakul S, Muhummudaree N, Techawiwattanaboon T, Gan L, Xu C, Kupwiwat R, Phattharapornjaroen P, Rojanathanes R, Leelahavanichkul A, Chatsuwan T. Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections. Sci Rep 2021;11:21676. [PMID: 34737361 DOI: 10.1038/s41598-021-01052-5] [Reference Citation Analysis]
11 Elmonir W, Abd El-Aziz NK, Tartor YH, Moustafa SM, Abo Remela EM, Eissa R, Saad HA, Tawab AA. Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt. Biology (Basel) 2021;10:373. [PMID: 33926062 DOI: 10.3390/biology10050373] [Reference Citation Analysis]
12 Pei N, Jian Z, Liu Y, Liang T, Liu W, Li J. Draft Genome Sequence of a Polymyxin-Resistant Klebsiella pneumoniae Clinical Strain Carrying mcr-8.1 and bla NDM-5. Microbiol Resour Announc 2021;10:e01224-20. [PMID: 33766905 DOI: 10.1128/MRA.01224-20] [Reference Citation Analysis]
13 Antonello RM, Principe L, Maraolo AE, Viaggi V, Pol R, Fabbiani M, Montagnani F, Lovecchio A, Luzzati R, Di Bella S. Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies. Antibiotics (Basel) 2020;9:E500. [PMID: 32785114 DOI: 10.3390/antibiotics9080500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Elias R, Duarte A, Perdigão J. A Molecular Perspective on Colistin and Klebsiella pneumoniae: Mode of Action, Resistance Genetics, and Phenotypic Susceptibility. Diagnostics (Basel) 2021;11:1165. [PMID: 34202395 DOI: 10.3390/diagnostics11071165] [Reference Citation Analysis]
15 Rossato L, Arantes JP, Ribeiro SM, Simionatto S. Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis 2021;102:115569. [PMID: 34775292 DOI: 10.1016/j.diagmicrobio.2021.115569] [Reference Citation Analysis]
16 Chiarelli A, Cabanel N, Rosinski-Chupin I, Zongo PD, Naas T, Bonnin RA, Glaser P. Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae. BMC Microbiol 2020;20:325. [PMID: 33109078 DOI: 10.1186/s12866-020-02007-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Basso M, Zago D, Pozzetto I, De Canale E, Scaggiante R, Biasolo MA, Peracchi M, Onelia F, Baldasso E, Palù G, Parisi SG. Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019. Int J Infect Dis 2020;92:81-8. [PMID: 31935535 DOI: 10.1016/j.ijid.2019.12.035] [Reference Citation Analysis]
18 Aslani S, Kiaei S, Afgar A, Morones-Ramírez JR, Aratboni HA, Faridi A, Rivera-Mackintosh LR, Kalantar-Neyestanaki D. Determination of incompatibility group plasmids and copy number of the bla NDM-1 gene in carbapenem-resistant Klebsiella pneumoniae strains recovered from different hospitals in Kerman, Iran. J Med Microbiol 2021;70. [PMID: 33999798 DOI: 10.1099/jmm.0.001361] [Reference Citation Analysis]
19 Criscuolo M, Trecarichi EM. Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences. Antibiotics (Basel) 2020;9:E58. [PMID: 32028615 DOI: 10.3390/antibiotics9020058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Touati A, Mairi A. Plasmid-Determined Colistin Resistance in the North African Countries: A Systematic Review. Microb Drug Resist 2021;27:121-33. [PMID: 32522081 DOI: 10.1089/mdr.2019.0471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pereira MF, Rossi CC, da Silva GC, Rosa JN, Bazzolli DMS. Galleria mellonella as an infection model: an in-depth look at why it works and practical considerations for successful application. Pathog Dis 2020;78:ftaa056. [PMID: 32960263 DOI: 10.1093/femspd/ftaa056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Cao X, Zhong Q, Guo Y, Hang Y, Chen Y, Fang X, Xiao Y, Zhu H, Luo H, Yu F, Hu L. Emergence of the Coexistence of mcr-1, bla NDM-5, and bla CTX-M-55 in Klebsiella pneumoniae ST485 Clinical Isolates in China. Infect Drug Resist 2021;14:3449-58. [PMID: 34483670 DOI: 10.2147/IDR.S311808] [Reference Citation Analysis]
23 Lam MMC, Wick RR, Watts SC, Cerdeira LT, Wyres KL, Holt KE. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun 2021;12:4188. [PMID: 34234121 DOI: 10.1038/s41467-021-24448-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
24 Maraolo AE, Scotto R, Zappulo E, Pinchera B, Schiano Moriello N, Nappa S, Buonomo AR, Gentile I. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials. Expert Rev Anti Infect Ther 2020;18:191-202. [PMID: 32011191 DOI: 10.1080/14787210.2020.1725473] [Reference Citation Analysis]
25 Fuster B, Tormo N, Salvador C, Gimeno C. Detection of two simultaneous outbreaks of Klebsiella pneumoniae coproducing OXA-48 and NDM-1 carbapenemases in a tertiary-care hospital in Valencia, Spain. New Microbes New Infect 2020;34:100660. [PMID: 32194965 DOI: 10.1016/j.nmni.2020.100660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Binsker U, Käsbohrer A, Hammerl JA. Global colistin use: A review of the emergence of resistant Enterobacterales and the impact on their genetic basis. FEMS Microbiol Rev 2021:fuab049. [PMID: 34612488 DOI: 10.1093/femsre/fuab049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Peng Q, Fang M, Liu X, Zhang C, Liu Y, Yuan Y. Isolation and Characterization of a Novel Phage for Controlling Multidrug-Resistant Klebsiella pneumoniae. Microorganisms 2020;8:E542. [PMID: 32283667 DOI: 10.3390/microorganisms8040542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Serral F, Pardo AM, Sosa E, Palomino MM, Nicolás MF, Turjanski AG, Ramos PIP, Fernández Do Porto D. Pathway Driven Target Selection in Klebsiella pneumoniae: Insights Into Carbapenem Exposure. Front Cell Infect Microbiol 2022;12:773405. [DOI: 10.3389/fcimb.2022.773405] [Reference Citation Analysis]
29 Lescat M, Magnan M, Kenmoe S, Nordmann P, Poirel L. Co-Lateral Effect of Octenidine, Chlorhexidine and Colistin Selective Pressures on Four Enterobacterial Species: A Comparative Genomic Analysis. Antibiotics (Basel) 2021;11:50. [PMID: 35052927 DOI: 10.3390/antibiotics11010050] [Reference Citation Analysis]
30 Chen T, Xu W, Yu K, Zeng W, Xu C, Cao J, Zhou T. In Vitro Activity of Ceftazidime-Avibactam Alone and in Combination with Amikacin Against Colistin-Resistant Gram-Negative Pathogens. Microb Drug Resist 2021;27:401-9. [PMID: 32721272 DOI: 10.1089/mdr.2019.0463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Stefaniuk EM, Tyski S. Colistin Resistance in Enterobacterales Strains - A Current View. Pol J Microbiol 2019;68:417-27. [PMID: 31880886 DOI: 10.33073/pjm-2019-055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
32 Morales-León F, Lima CA, González-Rocha G, Opazo-Capurro A, Bello-Toledo H. Colistin Heteroresistance among Extended Spectrum β-lactamases-Producing Klebsiella pneumoniae. Microorganisms 2020;8:E1279. [PMID: 32825799 DOI: 10.3390/microorganisms8091279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sonnevend Á, Ghazawi A, Darwish D, Barathan G, Hashmey R, Ashraf T, Rizvi TA, Pál T. In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula. Int J Infect Dis 2020;99:253-9. [PMID: 32738488 DOI: 10.1016/j.ijid.2020.07.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Anand T, Virmani N, Kumar S, Mohanty AK, Pavulraj S, Bera BC, Vaid RK, Ahlawat U, Tripathi BN. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J Glob Antimicrob Resist 2020;21:34-41. [PMID: 31604128 DOI: 10.1016/j.jgar.2019.09.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
35 Wang S, Liu H, Mao J, Peng Y, Yan Y, Li Y, Zhang N, Jiang L, Liu Y, Li J, Huang X. Pharmacodynamics of Linezolid Plus Fosfomycin Against Vancomycin-Resistant Enterococcus faecium in a Hollow Fiber Infection Model. Front Microbiol 2021;12:779885. [PMID: 34970238 DOI: 10.3389/fmicb.2021.779885] [Reference Citation Analysis]
36 Tian X, Huang C, Ye X, Jiang H, Zhang R, Hu X, Xu D. Molecular Epidemiology of and Risk Factors for Extensively Drug-Resistant Klebsiella pneumoniae Infections in Southwestern China: A Retrospective Study. Front Pharmacol 2019;10:1307. [PMID: 31736765 DOI: 10.3389/fphar.2019.01307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Sharahi JY, Hashemi A, Ardebili A, Davoudabadi S. Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran. Ann Clin Microbiol Antimicrob 2021;20:32. [PMID: 33906654 DOI: 10.1186/s12941-021-00437-8] [Reference Citation Analysis]
38 Kosar I, Dinc G, Eren E, Aykemat Y, Kilic M, Kilic H, Doganay M. Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae. North Clin Istanb 2021;8:113-8. [PMID: 33851073 DOI: 10.14744/nci.2020.14238] [Reference Citation Analysis]
39 Sah R, Khadka S, Shrestha GS, Acharya S, Aryal D, Shrestha P, Kattel HP, Shah NP, Pokhrel BM, Singh YP, Rijal B, Erdem H. Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal. Antimicrob Resist Infect Control 2019;8:155. [PMID: 31636898 DOI: 10.1186/s13756-019-0608-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
40 Nguyen LP, Park CS, Pinto NA, Lee H, Seo HS, Vu TN, Mai H, Pham AHT, Jang E, Cho YL, Goglin K, Nguyen K, White R, D'Souza R, Fouts DE, Yong D. In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea. Pharmaceuticals (Basel) 2021;14:370. [PMID: 33923801 DOI: 10.3390/ph14040370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Ali S, Alam M, Hasan GM, Hassan MI. Potential therapeutic targets of Klebsiella pneumoniae: a multi-omics review perspective. Brief Funct Genomics 2021:elab038. [PMID: 34448478 DOI: 10.1093/bfgp/elab038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Das A, Sahoo RK, Gaur M, Dey S, Sahoo S, Sahu A, Behera DU, Dixit S, Jain PS, Jain B, Sahu KK, Kumari KS, Subudhi E. Molecular prevalence of resistance determinants, virulence factors and capsular serotypes among colistin resistance carbapenemase producing Klebsiella pneumoniae: a multi-centric retrospective study. 3 Biotech 2022;12. [DOI: 10.1007/s13205-021-03056-4] [Reference Citation Analysis]
43 Marchetti VM, Bitar I, Sarti M, Fogato E, Scaltriti E, Bracchi C, Hrabak J, Pongolini S, Migliavacca R. Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy. Diagnostics (Basel) 2021;11:79. [PMID: 33418979 DOI: 10.3390/diagnostics11010079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]